Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Veracyte, Inc.
1112
Veracyte, Inc.
Health Care
Technology
Biotechnology
Veracyte, a pioneer in molecular cytology, develops molecular diagnostic tests that enable doctors to choose to avoid unnecessary invasive procedures.
Suggest edits
Founded
2008
Raised
$116M
Follow us
Also headquartered in South San Francisco
Genentech
SuccessFactors
Sutro Biopharma
Freenome
MyoKardia
Plenty
Theravance
Counsyl
Kinestral Technologies, Inc.
Principia Biopharma
Companies in the same industry
Glycemicon AG
Windtreetx
PULMOCIDE LIMITED
Bloomizon
Imutex
Storm Therapeutics
Finch Therapeutics Group
Prevail Therapeutics
PhyzData
InfoBionic
Alexa global traffic share
Twitter followers
Overview
Funding
4
Acquisitions
1
Add info
Latest funding
Show all
$45,000,000
Debt financing - 2016
$28,000,000
Venture capital (Series C) - 2013
Kleiner Perkins Caufield & Byers
TPG Biotech
GE Ventures
+2
Team Size
50+
Employees
I work here
Location
South San Francisco
Headquarters
Explore South San Francisco
Xconomy
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
MedCity News
Veracyte partners with J&J on development of lung cancer test
